On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

Lawyers for eight inspectors general suing the Trump administration over their firings were forced by an angry federal judge ...

MEXICO CITY—There were two notable holdouts among the world leaders who rushed to congratulate Joe Biden on his victory in the US elections: the leaders of Latin America’s two largest countries, both ...